Organization of chromatin in cancer cells: role of signalling pathways
- PMID: 10546890
Organization of chromatin in cancer cells: role of signalling pathways
Abstract
The role of mechanical and chemical signalling pathways in the organization and function of chromatin is the subject of this review. The mechanical signalling pathway consists of the tissue matrix system that links together the three-dimensional skeletal networks, the extracellular matrix, cytoskeleton, and nuclear matrix. Intermediate filament proteins are associated with nuclear DNA, suggesting that intermediate filaments may have a role in the organization of chromatin. In human hormone-dependent breast cancer cells, the interaction between cytokeratins and chromatin is regulated by estrogens. Transcription factors, histone acetyltransferases, and histone deacetylases, which are associated with the nuclear matrix, are components of the mechanical signalling pathway. Recently, we reported that nuclear matrix-bound human and chicken histone deacetylase 1 is associated with nuclear DNA in situ, suggesting that histone deacetylase has a role in the organization of nuclear DNA. Chemical signalling pathways such as the Ras/mitogen-activated protein kinase (Ras/MAPK) pathway stimulate the activity of kinases that modify transcription factors, nonhistone chromosomal proteins, and histones. The levels of phosphorylated histones are increased in mouse fibroblasts transformed with oncogenes, the products of which stimulate the Ras/MAPK pathway. Histone phosphorylation may lead to decondensation of chromatin, resulting in aberrant gene expression.
Similar articles
-
Chromatin organization and nuclear microenvironments in cancer cells.J Cell Biochem. 2008 Aug 15;104(6):2004-15. doi: 10.1002/jcb.21485. J Cell Biochem. 2008. PMID: 17668423 Review.
-
Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.Oncogene. 2002 Jan 24;21(5):719-30. doi: 10.1038/sj.onc.1205118. Oncogene. 2002. PMID: 11850800
-
Regulation and regulatory parameters of histone modifications.J Cell Biochem Suppl. 1998;30-31:203-13. J Cell Biochem Suppl. 1998. PMID: 9893272 Review.
-
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.Biochem Cell Biol. 2005 Feb;83(1):1-14. doi: 10.1139/o04-121. Biochem Cell Biol. 2005. PMID: 15746962 Review.
-
Signal transduction pathways and the modification of chromatin structure.Prog Nucleic Acid Res Mol Biol. 2001;65:299-340. doi: 10.1016/s0079-6603(00)65008-0. Prog Nucleic Acid Res Mol Biol. 2001. PMID: 11008491 Review.
Cited by
-
The application of histone deacetylases inhibitors in glioblastoma.J Exp Clin Cancer Res. 2020 Jul 18;39(1):138. doi: 10.1186/s13046-020-01643-6. J Exp Clin Cancer Res. 2020. PMID: 32682428 Free PMC article. Review.
-
Selective association of peroxiredoxin 1 with genomic DNA and COX-2 upstream promoter elements in estrogen receptor negative breast cancer cells.Mol Biol Cell. 2010 Sep 1;21(17):2987-95. doi: 10.1091/mbc.E10-02-0160. Epub 2010 Jul 14. Mol Biol Cell. 2010. PMID: 20631257 Free PMC article.
-
Protein complex, gene, and regulatory modules in cancer heterogeneity.Mol Med. 2008 Sep-Oct;14(9-10):543-5. doi: 10.2119/2008-00083.Papanikolaou. Mol Med. 2008. PMID: 18654660 Free PMC article. No abstract available.
-
Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.Neuromolecular Med. 2005;7(4):297-310. doi: 10.1385/NMM:7:4:297. Neuromolecular Med. 2005. PMID: 16391387
-
Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity.FASEB J. 2008 Jan;22(1):113-26. doi: 10.1096/fj.07-9078com. Epub 2007 Aug 27. FASEB J. 2008. PMID: 17724252 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases